Modulation of gene expression using zinc finger-based artificial transcription factors

Methods in Molecular Biology

Volumn 649, Issue , 2010, Pages 117-132

  Stolzenburg, Sabine ^a   Bilsland, Alan ^b   Keith, W Nicol ^b   Rots, Marianne G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

artificial transcription factors; Kr ppel associated box (KRAB); Transient gene expression modulation; valproic acid; VP64

Indexed keywords

CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ANIMAL; ARTICLE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PROMOTER REGION; PROTEIN ENGINEERING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; HUMANS; PROMOTER REGIONS, GENETIC; PROTEIN ENGINEERING; TRANSCRIPTION FACTORS; ZINC FINGERS;

EID: 84855460600     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-753-2_7     Document Type: Article

References (11)

1. Visser, A.E., Verschure, P.J., Gommans, W.M., Haisma, H.J., and Rots, M.G. (2006) Step into the groove: Engineered transcription factors as modulators of gene expression. Adv Genet. 56, 131-161.
2. Lu, Y., Tian, C., Danialou, G., Gilbert, R., Petrof, B.J., Karpati, G., and Nalbantoglu, J. (2008) Targeting artificial transcription factors to the utrophin A promoter: Effects on dystrophic pathology and muscle function. J Biol Chem. 283, 34720-34727.
3. Beltran, A., Parikh, S., Liu, Y., Cuevas, B.D., Johnson, G.L., Futscher, B.W., and Blancafort, P. (2007) Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene. 26, 2791-2798.
4. Kang, Y.A., Shin, H.C., Yoo, J.Y., Kim, J.H., Kim, J.S., and Yun, C.O. (2008) Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus. Mol Ther. 16, 1033-1040.
5. Sera, T. (2009) Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev. 61, 513-526.
6. Verschure, P.J., Visser, A.E., and Rots, M.G. (2006) Step out of the groove: Epigenetic gene control systems and engineered transcription factors. Adv Genet. 56, 163-204.
7. Beltran, A.S., Sun, X., Lizardi, P.M., and Blancafort, P. (2008) Reprogramming epigenetic silencing: Artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor. Mol Cancer Ther. 7, 1080-1090.
8. Carroll, D., Morton, J.J., Beumer, K.J., and Segal, D.J. (2006) Design, construction and in vitro testing of zinc finger nucleases. Nat Protoc. 1, 1329-1341.
9. Gommans, W.M., McLaughlin, P.M., Lindhout, B.I., Segal, D.J., Wiegman, D.J., Haisma, H.J., van der Zaal, B.J., and Rots, M.G. (2007) Engineering zinc finger protein transcription factors to downregulate the epithelial glycoprotein-2 promoter as a novel anti-cancer treatment. Mol Carcinog. 46, 391-401.
10. Zhao, J.Q., Hoare, S.F., McFarlane, R., Muir, S., Parkinson, E.K., Black, D.M., and Keith, W.N. (1998) Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene. 16, 1345-1350.
11. Shay, J.W. and Keith, W.N. (2008) Targeting telomerase for cancer therapeutics. Br J Cancer. 98, 677-683.